Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serhat Unal

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Vaccines|July 27, 2022
Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in TurkeyMeliha Cagla Sonmezer, Gulcin Telli Dizman, Enes Erul, et al.
Plos One|June 30, 2023
Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosisEmine Yaylali, Zikriye Melisa Erdogan, Fethi Calisir, et al.
Vaccines|February 26, 2022
Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in TurkeyMeliha Cagla Sonmezer, Enes Erul, Taha Koray Sahin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 30, 2021
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wardsDeniz C Guven, Imdat Eroglu, Rashad Ismayilov, et al.
Central European Journal of Public Health|March 6, 2014
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adultsEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
International Journal of Antimicrobial Agents|April 14, 2015
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up surveyMatthew Dryden, Arjana Tambic Andrasevic, Matteo Bassetti, et al.
Human Vaccines & Immunotherapeutics|June 26, 2024
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccinesMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Postgraduate Medicine|December 15, 2016
Turkish doctors' cohort: healthy despite low screeningSerhat Unal, Mine Durusu Tanriover, Sibel Ascioglu, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infectionsIftihar Koksal, Gurdal Yilmaz, Serhat Unal, et al.
Acta Clinica Belgica|September 15, 2005
Political issues in internal medicine in EuropeWerner Bauer, Petra-Maria Schumm-Draeger, Johannes Koebberling, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Vaccines|July 27, 2022
Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in TurkeyMeliha Cagla Sonmezer, Gulcin Telli Dizman, Enes Erul, et al.
Plos One|June 30, 2023
Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosisEmine Yaylali, Zikriye Melisa Erdogan, Fethi Calisir, et al.
Vaccines|February 26, 2022
Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in TurkeyMeliha Cagla Sonmezer, Enes Erul, Taha Koray Sahin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 30, 2021
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wardsDeniz C Guven, Imdat Eroglu, Rashad Ismayilov, et al.
Central European Journal of Public Health|March 6, 2014
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adultsEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
International Journal of Antimicrobial Agents|April 14, 2015
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up surveyMatthew Dryden, Arjana Tambic Andrasevic, Matteo Bassetti, et al.
Human Vaccines & Immunotherapeutics|June 26, 2024
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccinesMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Postgraduate Medicine|December 15, 2016
Turkish doctors' cohort: healthy despite low screeningSerhat Unal, Mine Durusu Tanriover, Sibel Ascioglu, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infectionsIftihar Koksal, Gurdal Yilmaz, Serhat Unal, et al.
Acta Clinica Belgica|September 15, 2005
Political issues in internal medicine in EuropeWerner Bauer, Petra-Maria Schumm-Draeger, Johannes Koebberling, et al.
Pageof 11